Lyn M. Huff - Concepedia

Author

Lyn M. Huff

National Cancer Institute ORCID

Also Known As

Huff, Lyn, Lyn Huff, Lyn M. Huff, Lyn Mickley Huff

Publications

748

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research National Institutes of Health Immunovaccine (Canada)Frederick National Laboratory for Cancer Research

About

Lyn M. Huff is an author at National Cancer Institute specializing in cell biology, medicine, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	165
2	Cell Biology	5	5	165
3	Health Sciences	1	1	52
4	Natural Sciences	1	1	37
5	Biochemistry	1	1	37

Lyn M. Huff

Publications

723

Citations

H-Index

Page 1

	Year	Citations
Histone Modifications at the <i>ABCG2</i> Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells Kenneth K.W. To, Orsolya Polgár, Lyn M. Huff, Molecular Cancer Research	2008	123
Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1) Yasumasa Honjo, Kuniaki Morisaki, Lyn M. Huff, Cancer Biology & Therapy	2002	116
Relationship of<i>EGFR</i>Mutations, Expression, Amplification, and Polymorphisms to Epidermal Growth Factor Receptor Inhibitors in the NCI60 Cell Lines Wanqing Liu, Xiaolin Wu, Wei Zhang, Clinical Cancer Research	2007	63
Characterization of Gene Rearrangements Leading to Activation of MDR-1 Lyn M. Huff, Jongseok Lee, Robert W. Robey, Journal of Biological Chemistry	2006	54
Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line Kevin G. Chen, Yan C. Wang, Marci E. Schaner, Cancer Research Abcb1 GeneCancer BiologyEpigeneticsTumor BiologyDrug Resistance	2005	52
Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter Robert W. Robey, Andrea N. Robinson, Fatima Ali-Rahmani, Scientific Reports	2021	43
A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma Hui Huang, Michael E. Menefee, Maureen Edgerly, Clinical Cancer Research	2010	42
Microtubule-Disrupting Chemotherapeutics Result in Enhanced Proteasome-Mediated Degradation and Disappearance of Tubulin in Neural Cells Lyn M. Huff, Dan L. Sackett, Marianne S. Poruchynsky, Cancer Research ProteasomeCytoskeletonPharmacotherapyCellular PhysiologyNeural Cells	2010	37
Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET Ido D. Weiss, Lyn M. Huff, Moses O. Evbuomwan, Oncotarget	2017	36
Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells V. Koneti Rao, Darawalee Wangsa, Robert W. Robey, Cancer Genetics and Cytogenetics Abcg2 Gene AmplificationSomatic VariantGliomaTumor HeterogeneityMedicine	2005	28

Page 1